Dynamic changes in systemic immune-inflammation index predict pathological tumor response and overall survival in patients with gastric or gastroesophageal junction cancer receiving neoadjuvant chemotherapy.

Demircan, Nazim Can; Atci, Muhammed Mustafa; Demir, Metin; Isik, Selver; Akagündüz, Baran

Demircan, Nazim Can; Atci, Muhammed Mustafa; Demir, Metin; Isik, Selver; Akagündüz, Baran.

Afiliación

Demircan NC; Department of Medical Oncology, Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
Atci MM; Department of Medical Oncology, Prof. Dr. Cemil Tasçioglu State Hospital, Istanbul, Turkey.
Demir M; Department of Medical Oncology, Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
Isik S; Department of Medical Oncology, Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
Akagündüz B; Department of Medical Oncology, Binali Yildirim University School of Medicine, Erzincan, Turkey.

Asia Pac J Clin Oncol ; 19(1): 104-112, 2023 Feb.

Article en En | MEDLINE | ID: mdl-35538045

Asunto(s)

Neoplasias Esofágicas; Neoplasias Gástricas; Humanos; Terapia Neoadyuvante; Estudios Retrospectivos; Quimioterapia Adyuvante; Neoplasias Gástricas/patología; Pronóstico; Neoplasias Esofágicas/tratamiento farmacológico; Neoplasias Esofágicas/patología; Unión Esofagogástrica/patología; Inflamación/tratamiento farmacológico

Palabras clave

gastroesophageal cancer; neoadjuvant chemotherapy; prognosis; systemic immune-inflammation index; tumor regression grade

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Asia Pac J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google